INTRODUCTION 18
The three best defined human influenza pandemics of the twentieth century may be 19 derived in whole or part from avian influenza viruses (2, 47, 48) , although the avian 20 origin is disputed for the most deadly human pandemic known, the 1918 H1N1 21 Recently, large scale influenza genome projects have produced sufficient avian (34) and 29 human (14) sequences to address fundamental questions. Given these resources, our 30 aim was to determine precisely which amino acid changes best distinguish an avian 31 influenza virus from a human influenza virus. After successfully identifying these 32 amino acids, we used them to assess the significance of mutations in H5N1 influenza 33 viruses isolated from humans. Furthermore, we defined a subset of these key amino 34 acids which allowed us to track mutations in the H1N1 influenza lineage over time. 35 36 Although these human influenza viruses are independent isolates, they are not 37 independent of lineage. The exact number of introductions is unknown, but these three 38 influenza pandemics account for the overwhelming number of human influenzas and 39 nearly all of the readily transmissible influenzas. As a result, a distinct amino acid from 40 these three founding strains is more likely to have arisen by coincidence than the large 41 sample size would suggest. Furthermore, the host and lineage parameters are so highly 42 correlated that destratification methods based on PCA (39) or other methods (35) will 43 erase the host effect. These methods have proven effective in other studies (39) . 44
However, our application of PCA based methods on the influenza sequence data failed 45 to resolve host from lineage. The interpretation of host and lineage are therefore 46 confounded. Specifically, we are precluded from determining whether hostdifferentiating amino acids are new adaptations or are due to the original lineages based 48 on sequence data alone. 49 However, host markers that arose due to lineage may reasonably be of biological 51 importance. As the successful colonization of human beings by influenza required the 52 viruses to overcome selective pressure, even the original founding viruses of each 53 lineage may reasonably be expected to contain important adaptations. Crucially, we can 54 discern likely biologically significant host markers from those that are trivial by 55 examining conservation. Since replication in influenza relies on low fidelity RNA 56 polymerases (41), a high rate of random mutations is observed. Thus, given a large 57 number of strains, we can estimate the expected frequency of amino acid substitution at 58 a given position and compare that estimate to the observed frequency These estimates 59 presume that the frequency of amino acid substitutions of the viruses do not vary 60 substantially within a host. Variability in the amino acid substitution frequency 61 between hosts is accounted for by our method (see Materials and Methods). (Table S1 ). Again the 220 majority of these markers reside in RNA replication complex proteins. We should 221 emphasize that it is unlikely that all 13 pandemic markers must be acquired to gain any 222 single phenotypic trait of pandemic influenza viruses such as efficient replication, tissue 223 tropism or transmissibility. Further, we cannot estimate how long it would take an 224 avian virus such as H5N1 to acquire these traits. avian isolates would acquire the 13 "pandemic" host markers, we can look at historical 228 data to determine whether early pandemic isolates acquired additional markers over 229 time. We can do this only for H1N1 isolates as they represent the introduction of all 8 230 influenza virus genes from an avian precursor, they have circulated in humans for 88 231 years, and many isolates have been sequenced. In contrast, subsequent pandemics 232 involved the introduction of only HA, NA, and PB1 genes from an avian isolate into a 233 pre-existing human strain, none of which carry host markers as defined by our criteria. M1 do not appear to be stably preserved, despite passing our 99% persistence criteria 244 (see methods). The instability of these markers in these genes may be due to the 245 reintroduction of H1N1 viruses from swine or birds or to seasonal variation in the 246 human host. 247
A C C E P T E D
The progressive changes seen in H1N1 human influenza isolates implies that these 248 viruses gradually acquired mutations that confer the phenotypic traits of seasonal 249 viruses and that these additional sites are not required for an influenza virus to cause a 250 pandemic. Rather it is likely that these additional mutations are associated with the 251 traits of seasonal influenza viruses such as low mortality. Over time, through 252 successive rounds of transmission and selection, we would expect avian influenzas, like 253 Persistent host markers in H5N1 viruses. We examined H5N1 influenza sequences 256 from avian hosts and compared them to H5N1 influenzas isolated from humans, 257 focusing on the 32 persistent host markers. We included 7 H5N1 strains recently 258 reported to transmit within a family in Indonesia (9). Although the predominant amino 259 acid found in H5N1 isolates is consistent with avian influenzas at most marker 260 locations, in a fraction of H5N1 isolates, the amino acid prevalent in human-hosted 261 viruses has been acquired. We found four sites that are significantly enriched (p < 262 0.0001) in human H5N1 isolates (Table 1) . Three of the four host markers that are 263 enriched in H5N1 are also 100% conserved in human pandemic isolates. These three 264 host markers are in PB2, one of which is the well known marker E627K. This mutation 265 was seen in all seven of the putatively human-transmissible Indonesian H5N1 viruses 266 (9) and in the 2003 H7N7 outbreak in the Netherlands (13). Four of the seven 267
Indonesian strains also have the PB2 host marker K702R. This novel marker site is 268 adjacent to a known high-pathogenicity site in PB2 at residue D701N (27). The 269 enrichment of four host markers in H5N1 isolates suggests H5N1 influenza can adapt to 270 human hosts. However, no single H5N1 virus sequenced contains more than two of 271 these four sites. 272
The polymerase protein PB2 appears critical to adaptation of avian viruses to humans, 273 based on this and other studies (9, 13). Significantly, we identify 10 PB2 host markers 274 here (Table A1 ). These are all high quality discriminators of host (95% or greater) and 275 all of these sites are preserved in 99% of human H1N1, H2N2 and H3N2 sequences 276 over time. Not only does PB2, along with PA, have the most persistent host markers, it 277 also has A199S, E627K, and K702R. These residues are the only host markers that are 278 absolutely (100%) conserved in all pandemic influenza isolates we surveyed (Table A1 ) 279
on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from that acquisition of the amino acids that are prevalent in humans are required for the 281 evolution of an avian influenza virus like H5N1 into a virus that is capable of causing a 282 human pandemic. Here we must note that the sporadic and modest acquisition of 283 markers in H5N1 human isolates and the stability of the H5N1 avian isolates indicate 284 that currently circulating H5N1 viruses are no more adapted to human hosts today than 285 they were in the past. What has changed is the geographic dispersion of the H5N1 virus 286 and thus the size of the population at risk. Therefore the current risk of an H5N1 287 influenza pandemic in humans is due to an increased frequency of human exposure to 288 the H5N1 virus from birds, rather than to a human adapted H5N1 virus. 289
Interestingly, two of these persistent host markers in PB2 occur in a unique set of four 290 H5N1 human isolates from Indonesia. These Indonesian influenza isolates are 291 distinguished from nearly all other human H5N1 isolates in that they may be acquired 292 by human to human transmission rather than by avian to human transmission (9). 293
Although the numbers are too small to allow a valid statistical test, these H5N1 isolates 294 from a single Indonesian family appear more adapted to humans than the other H5N1 295 human isolates presumably acquired directly from birds. The residue A199S in PB2 is 296 the only marker that is absolutely conserved in the seasonal human influenza isolates we 297 surveyed (Table A1) . 298
In summary, we have examined large collections of both avian and human influenza 299 protein sequences and identified persistent host markers across the influenza proteome. 300
By minimizing false positives and by focusing on those sites preserved over time in a 301 host dependent manner, we have identified a set of 32 amino acids which are persistent 302 host markers. These include both well known and novel sites, including a potential SH3 303 binding motif in NS1. By tracking the acquisition of these sites over time, we observed 304 evidence of progressive adaptation of the avian H1N1 virus to human hosts. We show 305
on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from pandemic viruses and suggest these are likely important in the evolution of pandemic 307 influenza. Further, we show that a small fraction of the population of H5N1 isolates 308 from humans have acquired four of these 32 markers, although no single H5N1 isolate 309 surveyed contains more than two markers and current H5N1 viruses are no more 310 adapted to humans today than they were in the past (Table 1) . 311
APPENDIX 312
Details concerning bioinformatic and statistical methods are provided in this 313 supplement. The persistence percentages, and proportional Euclidean distances are 314 given in Table A1 . A summary graphic of the proportional Euclidean distances by 315 genes is provided in Figure A1 and a frequency table of a key HA amino acid is shown 316 in Table A2 PB1. All amino acid markers from the genes HA, NA, and PB1 as well as the alternate 344 transcripts NS2, M2 and PB1-F2 were either poor quality host discriminators 345 (proportional Euclidean distance < 0.95) or were not preserved in human strains over 346 time (persistence < 99%). Host specific residues in HA have been reported elsewhere 347 (40), but HA residues do not differentiate more than 72% of viruses by host in this 348 broad study (proportional Euclidean distance of 0.72). Two studies have also reported 349 host-specific M2 sites (10, 28), however, these sites failed to pass thresholds used in this 350 study. The best M2 site V86A (V is the predominant avian residue and A is the 351 predominant human residue), did pass the Euclidean distance test, but failed the 99% 352 persistence test. Thus, by our stringent criteria, this M2 site is a valid host-specific 353 marker, but was excluded as a persistent host marker because it was not sufficiently 354 preserved in human influenzas over time. can be relieved at any number of sites, then the pressure to conserve a given site is 357 reduced as is the high degree of differentiation at that site. Direct evidence indicates 358 that HA receptor specificity can be altered by mutations at any one of several sites (16, 359 40, 50). Furthermore our survey of all HA sequences indicates that the amino acids at 360 key sites such as 226 in the HA receptor binding site are well preserved among avian 361 influenza isolates, but are not well preserved among human influenza isolates (Table  362 A2). We recognize that accurate alignments of HA and NA are hampered by high 363 variability and despite the care taken in manual editing, false negative errors may occur 364 due to alignment errors. While it might be possible to improve these alignments by 365 adding structural data, this data only exists for portions of each protein and for only a 366 few serotypes. Finally, while a lack of markers in HA and NA proteins are a concern, 367 we note that there is also a lack of markers in PB1, which was trivial to align due to 368 high conservation. Thus, it may be that residues in HA, NA, PB1 and PB1-F2 are 369 simply less host-differentiating than are other genes, as we have observed. 370 Statistical Tests. All statistical tests in this paper are performed on categorical data. 371
For each position we compared the frequency of amino acid categories across host using 372 a two sided chi-squared test. This test assumed independence of the categories and is in 373 common usage. For each position, the table size varied in accordance with the number 374 of amino acid types. For the host test, we decided not to fix the table size at 2 by 20 to 375 minimize table sparsity and to avoid false discoveries due to excessive degrees of 376 freedom. We relied on the strictness of the Bonferroni correction and the application of 377 absolute quality metrics to minimize false discoveries. 378
In total there were 4,728 aligned positions. Of these 611 positions passed the initial 379 screening. Including the initial screens as informal hypothesis tests there were 4,728 380 tests. The Bonferroni threshold at the 0.05 alpha level was 1.06 e-05. There were 599 381
A C C E P T E D
on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from applying the regression standardized residual threshold at -4 reduced this set to 61. This 383 list was further reduced by the use of absolute metrics, proportional Euclidean distance 384 and percent persistence. These metrics were chosen arbitrarily to guarantee minimum 385 quality standards. Sample sizes were dependent on the gene of interest (Table A3) . 386
The 32 remaining positions were then tested in H5N1 isolates for enrichment in human 387 versus avian hosts. As this test generated two-by-two tables, Fisher's exact test was 388 used. This two tailed test gives the most accurate p-value available under the 389 independence assumptions and is computationally feasible for small tables. Again a 390
Bonferroni threshold at the 0.05 alpha level was applied for these 32 tests. All results in 391 Figure 2 in 394 the main text were derived from the literature. The M1 interaction regions are based on 395 crystal structure (1) and viral assembly studies (3, 6, 18, 19, 31, 46) . M1 interacts with 396 other influenza viral proteins PA, NP, HA, PB1, and NS2 (18). M1 Also interacts with 397 Hsc70 (36) . NS1 interacts with binds eukaryotic initiation factor 4GI at the N terminus 398 (26), and has several protein binding domains (11, 25, 26) , including a SH3 domain 399 reported here for the first time (33). NP, PB1 (not pictured in Figure 2 ) and PB2 bind 400 each other in RNA polymerase complex formation (37, 38) . PA has casein kinase II 401 sites (42), and binds to the RNA cap (17) 
Regions of Protein Interaction. Known regions of protein interaction in
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